Skip Navigation
Skip to contents

ICoLA 2019

Today : 2019.05.27
D- 101
The 8th International Congress on Lipid & Atherosclerosis (ICoLA)
The 58th Fall Conference of the Korean Society of Lipid & Atherosclerosis
September 5 (Thu) ~ 7 (Sat), 2019
Conrad Seoul Hotel, Korea

Special Lectures

  • HOME
  • Program
  • Special Lectures

*(K) Korean Session

Symposium (K) Evolution of Big Data in Contemporary Healthcare Services
Chairpersons(TBD)
Sep. 5 (Thu.)
16:00~17:30
Room (TBD)
16:00-16:15 The Role of Biostatistics in Precision Medicine and Big Data Era Hyonggin An (Korea University, Korea)
16:15-16:30 Medical Big Data: Hype or Hope? Younghak Kim (Asan Medical Center, Korea)
16:30-16:45 EBenefit of Aspirin and Statin in Low Risk Hypertension: NHIS Data Analysis Chan Joo Lee (Yonsei University, Korea)
16:45-17:00 Unstable Obesity Parameters and Health Outcomes Based on NHIS Database Ga-Eun Nam (Korea University, Korea)
17:00-17:15 Prediction of Coronary Artery Disease Based on Precision Medicine Sungsoo Cho (Dankook University, Korea)
17:15-17:30 Discussion
Symposium Immune Regulation of Cardiovascular Disease
Chairpersons(TBD)
Sep. 5 (Thu.)
16:00~17:30
Room (TBD)
16:00-16:20 Immune Regulation of Cardiac Inflammation by Macrophages Kory Lavine (Washington University School of Medicine, St Louis, USA)
16:20-16:40 Immunometabolism of Macrophages in CVD Edward Benjamin Thorp (Northwestern University, Feinberg School of Medicine, USA)
16:40-17:00 Development of Molecular Probes for the Study of Atherosclerosis Young-Tae Chang (POSTECH, Korea)
17:00-17:20 Vascular Calcification in Atherosclerosis Chang Hyun Byon (Chonnam National University, Korea)
17:20-17:30 Discussion
Symposium Now It's Time to Focus on Variability
Chairpersons(TBD)
Sep. 6 (Fri.)
09:40~11:10
Room (TBD)
09:40-10:00 Blood Pressure Variability Sripal Bangalore (New York University, USA)
10:00-10:20 Body Weight Fluctuation Tae Jung Oh (Seoul National University, Korea)
10:20-10:40 Glycemic Variability and Cardiovascular Outcome Jae Hyeon Kim (Sungkyunkwan University, Korea)
10:40-11:00 Cholesterol Variability Seung Hwan Lee (The Catholic University of Korea, Korea)
11:00-11:10 Discussion
Symposium Beyond LDL-C: What Can Improve Dyslipidemia Care?
Chairpersons(TBD)
Sep. 6 (Fri.)
09:40~11:10
Room (TBD)
09:40-10:05 Imaging Modalities Can Guide Dyslipidemia Care Khurram Nasir (Center for Outcomes Research & Evaluation (CORE), Yale School of Medicine, USA)
10:05-10:30 Lipid Genetics Can Improve Dyslipidemia Care Sanghak Lee (Yonsei University, Korea)
10:30-10:55 Digital Health Can Improve Dyslipidemia Care Jung-Won Suh (Seoul National University Bundang Hospital, Korea)
10:55-11:10 Discussion
Symposium Evidenced-based Dietary Guidelines for CVD (Dyslipidaemia) Prevention
Chairpersons(TBD)
Sep. 6 (Fri.)
09:40~11:10
Room (TBD)
09:40-10:05 Updates on the Effect of Omega-3 Fatty Acids Supplementation on Prevention and Treatment of Dyslipidemia TBD
10:05-10:30 Functional Foods and Prevention of Dyslipidemia Sunmin Park (Hoseo University, Korea)
10:30-10:55 Dietary Factors and Cardiovascular Diseases in Large Population-based Prospective Cohort Study Kazumasa Yamagishi (University of Tsukuba, Japan)
10:55-11:10 Discussion
Symposium Single Cell Analysis
Chairpersons(TBD)
Sep. 6 (Fri.)
09:40~11:10
Room (TBD)
09:40-10:05 Basic of Single Cell RNA Sequencing Hae-Ock Lee (Samsung Medical Center, Korea)
10:05-10:30 Application of Single Cell RNA Sequencing Jong Kyoung Kim (DGIST, Korea)
10:30-10:55 Single Cell Epigenetics Sung-ho Park (UNIST, Korea)
10:55-11:10 Discussion
Symposium Hot Issues in Recent Lipid Guidelines
Chairpersons(TBD)
Sep. 6 (Fri.)
14:00-15:30
Room (TBD)
14:00–14:20 Practical Role of Ezetimibe in Lipid Guidelines Kwang Kon Koh (Gachon University, Gil Medical Center, Korea)
14:20–14:40 Role of PCSK9 Inhibitors in Lipid Guidelines and Future Perspectives Yu Kataoka (National Cerebral & Cardiovascular Centre, Japan)
14:40-15:00 Coronary Artery Calcium Score and Statin Therapy Joshua MItchell (Washington University School of Medicine, USA)
15:00-15:20 LDL Target in Lipid Guidelines Su Jin Jung (Sejong Hospital, Korea)
15:20-15:30 Discussion
Symposium Recent Evidence and Clinical Applications of Arterial Stiffness
Chairpersons(TBD)
Sep. 6 (Fri.)
14:00-15:30
Room (TBD)
14:00-14:20 Pulsatile Hemodynamics in Heart Failure Thomas Weber (Klinikum Wels-Grieskirchen, Austria)
14:20-14:40 Arterial Stiffness and Circardian Pattern of Blood Pressure  Jin-Sun Park (Ajou University Medical Center, Korea)
14:40-15:00 The Usefullness of Barachial-Ankle Pulse Wave Velocity Masanori Munakata (Tohoku Rosai Hospital, Japan)
15:00-15:20 Arterial Stiffness and Coronary Artery Disease  Hack-Lyoung Kim (SMG - SNU Boramae Medical Center, Korea)
15:20-15:30 Discussion
Symposium Novel Approaches in Lipidology and Atherosclerosis
Chairpersons(TBD)
Sep. 6 (Fri.)
14:00-15:30
Room (TBD)
14:00-14:25 Cholesterol Everywhere Man-Ho Choi (KIST, Korea)
14:25-14:50 Metabolomics: How Can We Use It for Metabolic Disease? Christine Des Rosiers (Université de Montréal, Canada)
14:50-15:15 Clonal Hematopoiesis; Is It a New Risk Factor for Metabolic Dysfunction? Chang Hee Jung (University of Virginia, USA)
15:15-15:30 Discussion
Symposium - KSoLA-JAS Joint Session Use of Non-statin Lipid-lowering Agents for Residual Risk Management
Chairpersons(TBD)
Sep. 6 (Fri.)
14:00-15:30
Room (TBD)
14:00-14:20 PCSK9 Inhibitors Atsushi Nohara (Kanazawa University, Japan)
14:20-14:40 Fibrates Shun Ishibashi (Jichi Medical University, Japan)
14:40-15:00 Ezetimibe Hyekyung Yang (Sungkyunkwan University, Korea)
15:00-15:20 TBD
15:20-15:30 Discussion
Symposium Glucose Metabolism and Cardiovascular Disease
Chairpersons(TBD)
Sep. 6 (Fri.)
16:30-18:00
Room (TBD)
16:30-16:50 TBD Chi Young Shim (Yonsei Univeristy, Korea)
16:50-17:10 TBD Seung-Hyun Ko (The Catholic University of Korea, Korea)
17:10-17:30 TBD Vincent Woo (University of Manitoba, Canada)
17:30-17:50 TBD Subodh Verma (University of Toronto, Canada)
17:50-18:00 Discussion
Symposium Blood Pressure in Lipid and Atherosclerosis
Chairpersons(TBD)
Sep. 6 (Fri.)
16:30-18:00
Room (TBD)
16:30-16:50 What is Optimal Target BP to Reduce Atherosclerosis? Jinho Shin (Hanyang University, Korea)
16:50-17:10 Regressive Effect of Pharmacological Therapy on Coronary Plaque- Anticipated Effects of ARBs and Statins on Patients with Ischemic Heart Disease Hideki Ishii (Nagoya University Hospital, Japan)
17:10-17:30 Management of Blood Pressure and Hyperlipidemia in Patients with Atherosclerosis TBD
17:30-17:50 Anti-hypertensive Effects of FMD (Fasting Mimicking Diet) and Cardiovascular Disease Manlio Vinciguerra (St'Anne University Hospital, Czech Republic)
17:50-18:00 Discussion
Symposium Reappraisal of Immune Cells in Cardiovascular Disease
Chairpersons(TBD)
Sep. 6 (Fri.)
16:30-18:00
Room (TBD)
16:30-16:50 The Role of Intestinal Microbial Homeostasis in Diet-Induced Atherosclerosis Ekaterina Koltsova (Fox Chase Cancer Center, USA)
16:50-17:10 The Role of LYVE1+ Macrophage in Atherosclerosis Veronique Angeli (National University of Singapore, Singapore)
17:10-17:30 Holo-Lipocalin-2–Derived Siderophores Increases Mitochondrial ROS and Impair OXPHOS in Cardiomyocytes Gary Sweeney (York University, Canada)
17:30-17:50 Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk Aimin Xu (The University of Hong Kong, Hong Kong)
17:50-18:00 Discussion
Symposium - KSoLA-IAS Joint Session Lipoprotein(a), a Crucial but Forgotten Risk Factor for Cardiovascular Disease
Chairpersons(TBD)
Sep. 6 (Fri.)
16:30-18:00
Room (TBD)
16:30-16:50 Epidemiology and Genetic Studies Showing an Association of Lp(a) with Elevated Cardiovascular Risk and Aortic Valve Disease Brian Tomlinson (The Chinese University of Hong Kong, Hong Kong)
16:50-17:10 Role of Lp(a) as CVD Factor and Its Inheritance in Familial Hypercholesterolemia Individuals Gerald Watts (The University of Western Australia, Australia)
17:10-17:30 Strategies for Lowering Lp(a) Levels Sang-Hyun Kim (Seoul National University, Korea)
17:30-17:50 The Implication of Lipoprotein(a) in Mebolic Diseases Eun-Jung Rhee (Sungkyunkwan University, Korea)
17:50-18:00 Discussion
Symposium Things to Consider When We Treat Dyslipidemia
Chairpersons(TBD)
Sep. 7 (Sat.)
09:40-11:10
Room (TBD)
09:40-10:05 One Size Doesn't Fit All: Ethnic Difference of CV Risk Anselm K Gitt (Klinikum Ludwigshafen, The Netherlands)
10:05-10:30 Statin is a Panacea? James A. Underberg (NYU Langone Health, USA)
10:30-10:55 Extremely Low LDL is Really OK? Kausik Ray (Imperial College London, UK)
10:55-11:10 Discussion
Symposium New Concept of HDL
Chairpersons(TBD)
Sep. 7 (Sat.)
09:40-11:10
Room (TBD)
09:40–10:05 Dysfunctional HDL – Bench to Clinic Robert S. Rosenson (The Mount Sinai Hospital in New York, USA)
10:05-10:30 Non RCT Role of HDL TBD
10:30-10:55 New Drug Targets to Raise HDL Cholesterol Sung Hee Choi (Seoul National University Bundang Hospital, Korea)
10:55-11:10 Discussion
Symposium Dietary Supplements for Prevention of CVD
Chairpersons(TBD)
Sep. 7 (Sat.)
09:40-11:10
Room (TBD)
09:40-10:05 Anti-inflammatory and Lipid-lowering Dietary Supplements for Reducing the Risk of Cardiovascular Disease Manohar Garg (University of Newcastle, Australia)
10:05-10:30 Bridging a Role of Vitamin D and Metabolomics in Dyslipidemia Eunmi Park (Hannam University, Korea)
10:30-10:55 Dietary Supplements for Preventing Cardiometabolic Risk in Korean Hyunjung Lim (Kyung Hee University, Korea)
10:55-11:10 Discussion
Symposium Bioactive Lipids and Diseases
Chairpersons(TBD)
Sep. 7 (Sat.)
09:40-11:10
Room (TBD)
09:40-10:00 Sphingolipid Metabolism and Hepatosteatosis Scott Summers (University of Utah, USA)
10:00-10:20 SMS2 and Lymphoma Infiltration Toshiro Okajaki (Kanazawa University of Medicine, Japan)
10:20-10:40 Phosphatidylcholine Metabolism Mee-Sup Yoon (Gachon University, Korea)
10:40-11:00 Inositol Phosphate Metabolism Seyun Kim (KAIST, Korea)
11:00-11:10 Discussion
Symposium Issused of Low LDL Cholesterol
Chairpersons(TBD)
Sep. 7 (Sat.)
15:20-16:50
Room (TBD)
15:20-15:40 Safety of Extreme Low LDL from an Analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration Brian A. Ference (University of Cambridge, UK)
15:40-16:00 Characteristics of Subjects with Very Low Serum Low-Density Lipoprotein Cholesterol and The Risk for Intracerebral Hemorrhage Dae Ho Lee (Gachon University, Gil Medical Center, Korea)
16:00-16:20 Hypertriglyceridemia and Low LDL-C Ki Hoon Han (Asan Medical Center, Korea)
16:20-16:40 Treatment and Low LDL-C In Kyung Jeong (Kyung Hee University, Korea)
16:40-16:50 Discussion
Symposium Air Pollution on Cardiovascular Disease
Chairpersons(TBD)
Sep. 7 (Sat.)
15:20-16:50
Room (TBD)
15:20-15:40 Perspective of Fine Particulate Air Pollution on CVD Rajagopalan Sanjay (Case Western Reserve University, USA)
15:40-16:00 Persistent Organic Pollutants on CVD Duk-Hee Lee (Kyungpook National University, Korea)
16:00-16:20 Chronic Air Pollutants on Endothelial Dysfunction Byoung Geol Choi (Korea University, Korea)
16:20-16:40 PM2.5-induced Arrhythmia Le Wi Lo (Taipei Veterans General Hospital, Taiwan)
16:40-16:50 Discussion
Symposium Targeting New Pathways to Treat Atherosclerotic Cardiovascular Disease
Chairpersons(TBD)
Sep. 7 (Sat.)
15:20-16:50
Room (TBD)
15:20-15:40 Lipid Signaling Pathways in Cardiac Energy Metabolism Jan F.C. Glatz (Maastricht University, The Netherlands)
15:40-16:00 Anti-obesogenic Treatment Modifies Cardiac Metabolism Terje Larsen (The Arctic University of Norway, Norway)
16:00-16:20 Ceremide and Fatty Liver Tae-Sik Park (Gachon University, Gil Medical Center, Korea)
16:20-16:40 Development of a Novel Assay for Vascular Disease Kyu-Tae Kang (Duksung Women’s University, Korea)
16:40-16:50 Discussion
Symposium - KSoLA-EAS Joint Session Familial Hypercholesterolemia is not Far Away
Chairpersons(TBD)
Sep. 7 (Sat.)
15:20-16:50
Room (TBD)
15:20-15:40 Lipoporotein Metabolic Derangements in FH Christoph Binder (Medicine of the Austrian Academy of Sciences, Austria)
15:40-16:00 Genetic Diagnosis of FH: What is New and What is Optimal? Seung-Tae Lee (Yonsei University, Korea)
16:00-16:20 Cost-effectiveness of Pharmacologic Treatment of FH HaeSun Suh (Pusan National University, Korea)
16:20-16:40 The FHSC Collaboration: Current Status and Future Developments Alberico L. Catapano (University of Milan, Italy)
16:40-16:50 Discussion
Organized by KSoLA

The Korean Society of Lipid and Atherosclerosis

  • Tel : +82-2-6203-1006, +82-2-3272-5330
  • Fax : +82-2-2-3445-0978
  • Email : ksla@lipid.or.kr
Room 1706, Taeyeong Desiang 320,Dongmak-ro, Mapo-gu, Seoul 04157, Korea
  • Business Registration Number : 110-82-60956
  • Chairman : Joong-Yeol Park

Secretariat of ICoLA 2019 │ People & Value, Inc.

C-1107, Doosan The Land Park, 161-8, Magokjungang-ro, Gangseo-gu, Seoul 07788, Korea

Copyrights 2019 © The Korean Society of Lipid and Atherosclerosis. All rights reserved.